Shing Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong Special Administrative Region, China

Similar documents
Seroepidemiological Evidence of Avian Influenza A Virus Transmission to Pigs in Southern China

Zoonotic potential of non-avian influenza A viruses

Influenza A Viruses (Evolution and Current Status) AND H3N2v Outbreak Update

Coordinating Global Surveillance for Influenza in Swine. OFFLU Swine Influenza Virus Group

Coordinating Global Surveillance for Influenza in Swine. OFFLU Swine Influenza Group

Current Vaccines: Progress & Challenges. Influenza Vaccine what are the challenges?

OIE Situation Report for Highly Pathogenic Avian Influenza

OIE Situation Report for Highly Pathogenic Avian Influenza

SEA/CD/154 Distribution : General. Avian Influenza in South-East Asia Region: Priority Areas for Research

Sponsors. Production Assistants Steven Claas Lynn Leary. Layout David Brown

Influenza at the human-animal interface

Contribution of avian influenza data through OFFLU network

OIE Situation Report for Avian Influenza

OIE Situation Report for Highly Pathogenic Avian Influenza

Current CEIRS Program

Global Challenges of Pandemic and Avian Influenza. 19 December 2006 Keiji Fukuda Global influenza Programme

M E E T I N G R E P O R T. Expert Group Meeting on Swine Influenza in Asia Pacific Region

OIE Situation Report for Avian Influenza

OFFLU Technical Meeting Coordinating world-wide surveillance for influenza in swine OIE Paris, 6-7 April 2011

OFFLU the joint OIE-FAO network of expertise on animal influenza

Recommended composition of influenza virus vaccines for use in the influenza season

OIE Situation Report for Avian Influenza

Avian influenza viruses from the global perspective

I. H. Brown*, S. M. Reid, G. Simon, W. Loeffen, L. E. Larsen, P. Kellam, S.Watson, N. Lewis, S. M. Brookes, O.Pybus & ESNIP3 Consortium

Research Issues in Animal Surveillance and Pandemic Planning

Agricultural Outlook Forum Presented: February 16, 2006 THE CURRENT STATE OF SCIENCE ON AVIAN INFLUENZA

Emergence and Changes in swine and avian influenza viruses of Pandemic Potential

Emergence of distinct avian-like influenza A H1N1 viruses in pigs in Ireland and their reassortment with cocirculating H3N2 viruses

Existence of reassortant A (H1N2) swine influenza viruses in Saitama Prefecture, Japan

Supporting Online Material for

Development of an Influenza Risk Assessment Tool

OFFLU Technical Meeting Coordinating world-wide surveillance for influenza in swine. OIE headquarters, Paris, France March 27-28, 2012

OIE Situation Report for Avian Influenza

Questions and Answers

OFFLU STEERING AND EXECUTIVE COMMITTEE MEETING 31 March 2017 FAO Headquarters, Rome

Kyoung-Jin Yoon 1, Bruce H. Janke, Rick W. Swalla, Gene Erickson

OIE s initiative on HPAI control

FluSure XP TM Update with Regards to 2009 H1N1 Swine Influenza Virus

Min Levine, Ph. D. Influenza Division US Centers for Disease Control and Prevention. June 18, 2015 NIBSC

Global updates on avian influenza and tools to assess pandemic potential. Julia Fitnzer Global Influenza Programme WHO Geneva

Influenza Testing Today: Keeping Up with a Moving Target

Before and during influenza pandemics

Outbreaks and control of swine influenza viruses in Korea

Recommended composition of influenza virus vaccines for use in the 2007 influenza season

The surveillance and control programme for specific virus infections in swine herds in Norway 2012

In April 2009, a new strain of

OIE Situation Report for Avian Influenza

MINI-REVIEW. Protein & Cell. The emergence of pandemic influenza viruses

Influenza Viruses A Review

AVIAN INFLUENZA & NEWCASTLE ACTIVITIES

Avian Influenza A(H7N9) 6 February 2014 Surveillance Update

INFLUENZA-2 Avian Influenza

Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness

Influenza Virus Circulation in Swine of Southern Vietnam, 2009 ABSTRACT

Surveillance and control programmes for terrestrial and aquatic animals in Norway

Countries initially targeted: Bangladesh, Mongolia, Myanmar, Nepal, Lao People s Demoncratic Republic and Pakistan.

Chinese Influenza Weekly Report

Avian influenza - current situation and future trends

Preparing for the Fall Flu Season. Jonathan Gubbay Medical Microbiologist Public Health Laboratory OAHPP

Chinese Influenza Weekly Report

Global Pandemic Preparedness Research Efforts. Klaus Stöhr. WHO Global Influenza Programme. Today

Avian Influenza (AI) National & International Update

Promoting Public Health Security Addressing Avian Influenza A Viruses and Other Emerging Diseases

Chinese Influenza Weekly Report

Citation Journal Of Virological Methods, 2008, v. 154 n. 1-2, p

Evaluation of Routine Serological Diagnostic Methods for the 2009 Pandemic Influenza A (H1N1) Virus

Influenza: Ecology and Continuing Evolution

The influenza A viruses of swine in Japan, Thailand, and Vietnam

Segments 7 codes for M1 and M2 proteins (Matrix proteins)

Ian Brown AHVLA-Weybridge ESNIP3 coordinator

Surveillance Overview

Avian influenza Avian influenza ("bird flu") and the significance of its transmission to humans

Correlates of Protection for Flu vaccines and Assays Overview. by Simona Piccirella, PhD Chief Executive Officer

OIE Reference Laboratory Reports Activities

Chinese Influenza Weekly Report

FAO contribution to the OFFLU swine influenza group

Influenza Update N 157

Application of Reverse Genetics to Influenza Vaccine Development

Cluster-Randomized Controlled Trial of a Brief Theory-Based Avian Influenza Prevention Program for Poultry Workers in Taiwan

Swine Influenza Virus Surveillance Canada John Pasick Guelph, Ontario, Canada

Global and Regional Strategies for HPAI and CSF

Review of Vaccine and Vaccination Component in Global Avian Influenza Control Strategies

Influenza Update N 176

Antigenic categorization of contemporary H3N2 Swine influenza virus isolates using a high-throughput serum neutralization assay

Highly pathogenic avian influenza A(H5N1) viruses

Global antigenic cartography publication, ongoing cross H1 and H3 antigenic characterisation

Avian Influenza: Armageddon or Hype? Bryan E. Bledsoe, DO, FACEP The George Washington University Medical Center

Introduction to Avian Influenza

ph1n1 H3N2: A Novel Influenza Virus Reassortment

Principles for event based and active avian influenza surveillance. Les Sims Asia Pacific Veterinary Information Services

Avian Influenza (Bird Flu) Fact Sheet

Control and surveillance of H7N9 Avian Influenza in China


Evaluation of New Rapid Antigen Test for the Detection of Pandemic. Influenza A/H1N Virus

SCIENTIFIC DISCUSSION

National Strategies for Controlling Avian Influenza Viruses

Review of diagnostic tests for SIV s and pandemic H1N1 in pigs. Ian Brown. Veterinary Laboratories Agency- Weybridge

Advanced Lecture on One Health

Where Health Care Meets Policy. with Dr. Mike Magee

Transcription:

CVI Accepts, published online ahead of print on 4 January 2012 Clin. Vaccine Immunol. doi:10.1128/cvi.05358-11 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Evaluation of three commercially available influenza A type-specific blocking-elisa assays for seroepidemiological studies of influenza A virus infection in pigs. 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Maying Tse 1, Mia Kim 2, Chung-Hei Chan 1, Po-Lai 1 Ho 1, Siu-Kit Ma 1, Yi Guan 1, JSM Peiris 1 1 State Key Laboratory of Emerging Infectious Diseases & School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong Special Administrative Region, China 2 Emergency Centre for Transboundary Animal Diseases, Animal Production and Health Division, Food and Agriculture Organization of the United Nations, Viale delle Terme di Caracalla, 00153 Rome, ITALY Running title: ELISA assays for swine influenza serology Key words: serology, swine influenza, epidemiology, ELISA Corresponding author: JSM Peiris, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong Special Administrative Region, China E mail: malik@hkucc.hku.hk Telephone: (852)-9389 3736 Fax: (852)-2855-1241

23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 Abstract: The reverse zoonotic transmission of the pandemic H1N1 2009 virus to swine necessitates enhanced surveillance of swine for influenza virus infection. Using a well characterized panel of naturally infected swine sera we evaluate and optimize the performance of three commercially available competitive ELISA assays, IDEXX Influenza A Ab test, IDEXX AI MultiS-Screen Ab Test and IDVet ID Screen Influenza A Antibody Competition ELISA kit for detecting influenza type A reactive antibodies in swine. ROC analysis suggests that adjustment of the manufacturer recommended cut-off values would optimize sensitivity and specificity of these assays making them applicable for sero-epidemiology studies of swine influenza. Using such optimized cut-off levels, sensitivity and specificity of the IDEXX Influenza A Ab test was 86% and 89% respectively; for IDEXX AI MultiS-Screen Ab Test was 91% and 87% and for IDVet ID Screen Influenza A was 95% and 79%, respectively. Introduction: The emergence of the pandemic H1N1 2009 (H1N1pdm) virus of swine-origin (3) and its transmission back to swine (6-8) heightened the need for global surveillance of swine influenza (see recent meeting report http://www.offlu.net/offlu%20site/siv- Summary_final.pdf). Seroepidemiology provides useful information on swine influenza virus activity. However hemagglutination inhibition (HI) or microneutralization assays are subtype and partially virus-lineage specific, and studies carried out with a limited or poorly chosen panel of virus antigens may underestimate true seroprevalence. This is particularly relevant where there is a paucity of virological data, e.g. many parts of Asia, Africa, and South America. There is limited data on the performance of influenza A type-specific ELISA assays for seroepidemiology in swine. ELISA assays specific for H1N1 and H3N2 subtype swine influenza virus antibodies respectively had poor sensitivity in pigs experimentally infected or vaccinated with Eurasian avian-like swine influenza viruses (1). Competitive ELISA assays that detect cross-reactive antibodies to type A influenza viruses are used for surveillance of avian influenza in poultry and would be potentially useful for seroepidemiology of swine. The IDEXX AI MultiS-Screen Antibody Test Kit gave good sensitivity and specificity on

54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 sera from pigs with known infection history for North American swine influenza viruses, provided adjustments were made to the S/N cutoff by reference to the ROC curve (2). The aim of the present study was to evaluate the test performance characteristics of three commercially available competitive ELISA assays which detect influenza Type A crossreactive antibodies for detection of influenza A antibody in swine sera. Materials and Methods: ELISA tests: The tests evaluated were IDVet ID Screen Influenza A Antibody Competition ELISA kit, ID VET - Innovative Diagnostics, France (product code FLUACA-2P), and two versions of IDEXX tests, IDEXX AI MultiS-Screen Antibody Test (USDA licensed for serology in five domestic poultry species, not for swine) (product code 99-12119) and the IDEXX Influenza A Ab Test, Maine (product code 99-53101) (marketed outside of North America with claimed applicability in avian, canine, feline and swine species; uses different cut-off for swine sera). These tests were used according to the manufacturers instructions. Panel of sera used for test evaluation: We used a panel of well characterized sera from our 13-year systematic abattoir-based virological and serological surveillance for swine influenza in southern China where all three major virus H1 lineages, viz. classical swine (CS), Eurasian avian-like swine (EA) and North American Triple reassortant viruses (TRIG), as well as EA H3N2 and human like H3N2 viruses were found to co-circulate (9). The sera were collected at the largest abattoir in Hong Kong where approximately 4000 pigs are slaughtered daily, 95% of the pigs being sourced from 12 provinces across China. The pigs were apparently healthy on arrival at the abattoir and their past infection status was determined on detection of HI antibody to a range of well-chosen viral antigens (see below). We selected a panel of 116 sera that had been tested in HI assays using a panel of 9 swine influenza viruses chosen to represent the different virus subtypes and antigenically variant virus lineages known to be active in our study area (9).. Virus antigens from six H1 influenza A viruses: CS lineage - A/swine/HK/4167/1999 (H1N1), A/swine/HK/1304/2003 (H1N2); TRIG lineage (H1N2) - A/swine/HK/1110/2006; EA lineage (H1N1)- A/swine/HK/NS29/2009, A/swine/HK/1559/2008; an H1N1pdm virus A/Ca/04/2009; and three H3N2 viruses - A/sw/HK/5212/1999 (Eurasian-avian-like), A/sw/HK/1128/2003 (human-like) and A/sw/HK/2422/1998 (human-like) were used. Thirty-eight were seronegative to all 9 antigens and the other 78 sera were selected to represent sera that were seropositive to one or more of these viruses at varying antibody titers. The percentage seropositivity of the 78 seropositive

86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 test sera were as follows: CS lineage - A/Sw/HK/4167/1999 (H1N1) 87%, A/Sw/HK/1304/2003 (H1N2) 58%, TRIG lineage (H1N2) - A/Sw/HK/1110/2006 86%; EA lineage (H1N1) A/Sw/HK/NS29/2009 78%; A/Sw/HK/1559/2008 56%; H1N1pdm A/Ca/04/2009 54%; and the H3N2 viruses A/Sw/HK/5212/1999 6%; A/Sw/HK/1128/2003 (H3N2) 1%; A/Sw/HK/2422/1998 (H3N2) 4%. Seventy three of 78 sera were seropositive to more than one reference antigen; this may reflect either multiple infections and / or serological cross-reactivity between virus antigens of antigenically related virus groups (9). A negative and positive control swine serum (based on HI tests) was used in each experiment. Analysis: To allow comparison between the IDVet and IDEXX tests, we have expressed the results as a ratio of ELISA assay optical density of specimen/negative control (S/N). The statistical analysis was carried out using the software program MedCalc. Sensitivity, specificity, positive and negative predictive values, Receiver Operation Characteristic (ROC) and Youden index were computed as described elsewhere (4). Results: At the manufacturer s recommended cutoff for each test (see table legend for details), the sensitivity of the IDVet, IDEXX AI MultiS and IDEXX IA Ab Test was 69% [95% confidence interval (CI) 58-79]; 82% [95% CI 73-91] and 86% [95% CI 76-93] respectively (Table 1; Figure 1). The specificity for the three assays was 89%; 87% and 79% respectively. The ROC curve (5) identifies test kit cutoff values for each test kit that may provide optimal test sensitivity and specificity (Table 1; Figure 1); the optimal S/N cut-off ratio for IDVet being 0.71 (kit recommended cut-off 0.5) and for both IDEXX assays is 0.56. Table 1 presents test characteristics using a) the manufacturers recommended cut-off SN ratio, b) the optimal SN ratio derived from the ROC curve and the Youden index, and c) the SN ratios giving the highest and lowest sensitivity and specificity respectively, in the ROC curve. The positive and negative predictive values were also calculated (table 1) but as the analysis was done on a panel of sera pre-selected to have different HI antibody reaction profiles, these predictive values need to be interpreted with caution. Figure 2 illustrates the correlation between the IDVet and IDEXX IA Ab Test ELISA assays in relation to whether each serum was seropositive or seronegative to the panel of HI tests. Excellent correlation was found between the IDEXX IA Ab Test and the IDEXX AI MultiS

117 118 119 assays (data not shown). We understand from the manufacturer that the components used in the manufacture of these two assays are the same, though the test kits are packaged in two separate locations and are targeted at two different markets. 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 Discussion The findings of this study indicate that the competitive ELISA assays we evaluated can be used for sero-epidemiological studies of swine influenza. The sensitivity and specificity of the tests for swine sera can be improved by selecting the SN ratio (test cut off) based on the ROC curve we have generated rather than using the SN ratio recommended by the manufacturer. The reason for the sub-optimal test cut-off SN ratios for some tests is probably a consequence of the tests being designed and validated mainly on poultry sera rather than on swine sera and indeed two of the tests are not marketed for use on swine sera. For seroepidemiological studies, however, positive results by these ELISA tests would provide evidence of the circulation of influenza viruses in swine, even when local swine influenza virus isolates are unavailable. Sera that are positive in the ELISA assays can then be tested further in HI tests with representative virus antigens to identify the virus lineages that are likely to be prevalent in a given geographic region. Three of the 38 sera that were seronegative in HI tests to the antigen panel were positive in all three ELISA tests (Figure 2); perhaps evidence of seropositivity to an influenza virus (of swine or even avian origin) that is not represented in the HI test reference antigen panel used for this study. This may provide an impetus for further serological testing against other influenza viruses. For the analysis of test performance characteristics (Table 1, Figure 1) we assumed that sera that were seronegative by HI tests to all the test antigens were true negatives. However, because these ELISA assays target conserved anti-influenza A nucleoprotein antibodies, it is possible that some sera which are HI negative but ELISA positive (i.e. currently regarded as false positive) may be truly positive to a swine influenza virus antigen not represented in our panel. The specificity and the negative predictive values in our analysis must be interpreted with this caveat in mind. The false negative results were randomly distributed across the different virus lineages. Many (but not all) of them have ELISA optical density values that are close to the cut-off level but there is no correlation with the HI titre of respective sera (data not shown).

148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 In summary, our results indicate the feasibility of using competitive ELISA assays as screening tests for seroepidemiology of swine influenza, providing their limitations are recognised. The detection of swine influenza virus antibody by the application of such competitive ELISA assays with broad influenza A type reactivity would provide impetus for virological surveillance to detect the viruses circulating in a given geographic region. In time, such an effort would allow the assembly of panels of relevant viral HI antigens that covers swine influenza virus activity in a regional (if not global) context. As with any serological test, alternative explanations for seropositivity such as vaccination needs to be considered, but vaccination of swine for influenza is uncommon in many Asian and African countries. Acknowledgments: We thank the OIE-FAO Network of expertise for animal influenza (www.offlu.net) for providing the platform for exchange of ideas and the Food and Agriculture Organization of the UN (FAO) for contributing some kits for evaluation. We acknowledge research grant funding from the National Institute of Allergy and Infectious Diseases (NIAID) contract HHSN26600700005C and the Area of Excellence Scheme of the University Grants Commission (grant AoE/M-12/06) of the Hong Kong SAR Government.

165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 Figure legends: Figure 1: Receiver operating characteristic (ROC) curve on panel of sera tested with three competitive ELISA assays which detect influenza type A cross-reactive antibodies, a) IDVet ID Screen Influenza A Antibody Competition ELISA kit, ID-Vet, France, b) IDEXX Influenza A Ab Test, Maine, USA and c) IDEXX AI MultiS-Screen Antibody Test (USDA licensed for serology in five domestic poultry species, not for swine). The read-out for all three tests is expressed as specimen/negative control (S/N) ratio. The sensitivity and specificity at different S/N ratios are shown. The % true positive rate (sensitivity) and % false positive rate (100-% specificity) at different S/N ratios are shown. The recommended S/N cut-off for a positive result in the IDVet and IDEXX AI MultiS-screen tests was 0,5 and that for the IDEXX Influenza A Ab Test was 0.6 for swine sera. The boxed line indicate the sensitivity and specificity calculated for each serum sample; the dotted lines are the 95% confidence intervals CI intervals; the diagonal line represents what would be expected if the test results were generated at random. The area bounded by the boxed line and the diagonal is the Area Under the Curve (AUC) of the ROC curve. A larger AUC implies that the test results are not likely to be random. The arrows denote the SN ratios corresponding to those shown in table 1. Figure 2: The correlation scatter-plot of S/N ratio results obtained for 116 sera tested using the IDVet ID Screen Influenza A Antibody Competition ELISA kit and the IDEXX Influenza A Ab Test. Sera that were antibody positive by hemagglutination inhibition (HI) assay to one or more virus antigens are denoted as closed circles and those HI negative to all antigens are denoted in open circles. The S/N ratio cut-offs, denoted by a dotted line, were 0.5 and 0.6, respectively for the IDVet test and IDDEX tests.

189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 References: 1. Barbe, F., Labarque, G., Pensaert, M., Van Reeth, K. 2009. Performance of commercial swine influenza virus H1N1 and H3N2 antibody enzyme-linked immunosorbent assay in pigs experimentally infected with European influenza viruses. J Vet Diagn Invest. 21: 88-96. 2. Ciacce-Zanella, J.R., Vincent, A.L., Prickett, J.R., Zimmerman, S.M., Zimmerman, J.J. 2010. Detection of anti-influenza A nucleoprotein antibodies in pigs using a commercial influenza epitope-blocking enzyme-linked immunosorbent assay developed for avian species. J Vet Diagn Invest 22: 3-9. 3. Garten, R. J., et al. 2009. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197-201. 4. Greiner, M. et al. 2000. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Preventive Veterinary Medicine. 45:23-41 5. Hanley, J. A., and B. J. McNeil. 1982. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29-36. 6. Pereda A, et al. 2011. Evidence of reassortment of pandemic H1N1 influenza virus in swine in Argentina: are we facing the expansion of potential epicenters of influenza emergence? Influenza Other Respi Viruses. doi: 10.1111/j.1750-2659.2011.00246.x. 7. Starick E, et al. 2011. Reassorted pandemic (H1N1) 2009 influenza A virus discovered from pigs in Germany. J Gen Virol. 92:1184-8. 8. Vijaykrishna, D., et al. 2010. Reassortment of pandemic H1N1/2009 influenza A virus in swine. Science 328:1529. 9. Vijaykrishna, D., et al. 2011. Long-term evolution and transmission dynamics of swine influenza A virus. Nature 473:519-22.

Table 1. The test performance characteristics of three competitive ELISA tests for detecting influenza type A antibody. Parameter and group Sensitivity Specificity Performance characteristics [95% CI a ] of tests at different specimen / negative control (S/N) ratios IDVet ID Screen IDEXX AI MultiS IDEXX IA Ab 0.23 b 0.5 0.71 0.74 0.14 0.5 0.57 0.69 0.21 0.56 0.6 0.78 45 (34-57) 69 (58-79) 95 (87-99) 97 89 79 (86-100) (75-97) (63-90) 96 (89-99) 46 (35-58) 82 (73-91) 91 (82-96) 76 97 87 87 (60-89) (86-100) (69-94) (72-96) 96 (89-99) 42 (31-54) 86 (76-93) 86 (76-93) 96 (89-99) 74 97 89 79 61 (57-87) (86-100) (75-97) (63-90) (43-76) PPV a 94 93 90 88 97 93 93 83 97 94 89 83 NPV a 56 59 86 93 46 70 80 88 45 76 73 88 J a 42 59 74 72 43 69 78 70 39 75 65 57 AUC a 0.922 0.915 0.901 SE a 0.0314 0.0327 0.0351 a Abbreviations: CI, confidence interval; PPV positive predictive value; NPV negative predictive value; J, Youden Index; AUC, area under curve; SE, standard error (see ref 4) b ELISA optical density ratio of specimen//negative control (S/N). To allow comparison between the IDVet and IDEXX tests, we have expressed the results of the IDVet assay also as an S/N ratio rather than as % competition. Then the kit recommended S/N cut-offs for a positive result was <0.5 for both the IDVet and IDEXX AI MultiS assays (for avian sera) and <0.6 with the IDEXX IA Ab test (for swine sera). The optimal cut-off for each assay as determined by the Youden Index (J) analysis of our data is indicated in bold. In addition, the lowest SN ratio giving specificity 97% and specificity 96% is denoted.